Results 11 to 20 of about 117 (67)
Cell-Free DNA Methylome and Fragmentome Analysis for Relapse Monitoring of Ewing Sarcoma
Liquid biopsies and cell-free DNA (cfDNA) offer minimally invasive methods for the diagnosis and monitoring of Ewing Sarcoma (EwS). EwS have a low tumour mutational burden and their detection with plasma cfDNA is challenging.
Florent Mouliere +2 more
exaly +3 more sources
Multimodal epigenetic characterization of cell-free DNA (cfDNA) could improve the performance of blood-based early cancer detection. However, integrative profiling of cfDNA methylome and fragmentome has been technologically challenging. Here, we adapt an
Fenglong Bie +24 more
doaj +2 more sources
Identification of ᴅ-amino acid-containing peptides in human serum. [PDF]
Biologically uncommon d-aspartate (d-Asp) residues have been shown to accumulate in proteins associated with age-related human disorders, such as cataract and Alzheimer disease.
Seongmin Ha +6 more
doaj +2 more sources
Liquid biopsy for early detection of hepatocellular carcinoma [PDF]
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer globally. Over 90% of HCC cases arise in the context of liver cirrhosis, and the severity of the underlying liver disease or advanced tumor stage at diagnosis significantly limits ...
Ioana Manea +20 more
doaj +2 more sources
Cell‐free DNA (cfDNA) can be isolated and sequenced from blood and/or urine of cancer patients. Conventional short‐read sequencing lacks deployability and speed and can be biased for short cfDNA fragments.
Florent Mouliere +2 more
exaly +2 more sources
qMAP decodes RNA fragmentation dynamics in development and disease
Noncanonical small RNAs, such as tRNA-derived (tsRNAs) and rRNA-derived (rsRNAs) fragments, are more abundant than microRNAs and arise from selective cleavage events rather than random degradation.
Hukam C Rawal +5 more
doaj +2 more sources
Summary: Cell-free DNA (cfDNA) in plasma provides attractive opportunities for early cancer diagnosis. This study aimed to establish gastric cancer (GC) artificial intelligence algorithms (GC-AIAs) based on cfDNA fragmentome for GC’s early detection and ...
Ziao Lin, Wenjia Liu, Dingding Hou
exaly +3 more sources
Background Cell-free DNA (cfDNA) is a powerful analyte for liquid biopsy applications. However, the composition and fragmentation of cfDNA in health remains incompletely characterized. Understanding this baseline variation is key to advancing cfDNA-based
Joris R Vermeesch +2 more
exaly +2 more sources
BackgroundResearch in the developmental origins of health and disease provides compelling evidence that adverse events during the first 1000 days of life from conception can impact life course health.
Joshua J Fisher +12 more
doaj +2 more sources
PALM‐Seq simultaneously characterizes the abundance and molecular signature of cell‐free coding and non‐coding RNAs. The profiles and end motifs of cf‐mRNA and cf‐lncRNA can distinguish biofluids. Seminal plasma tends to retain longer fragments than other biofluids.
Zhongzhen Liu +16 more
wiley +1 more source

